This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Intern Med. 1996;156(21):2414.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE NONSTEROIDAL anti-inflammatory drugs (NSAIDs), whose volume of use is among the highest of all therapeutic agents, function as anti-inflammatory modalities by inhibiting the production of prostaglandins involved in inflammation. As a corollary, prostaglandin inhibition also causes the most common form of NSAID-induced kidney impairment.¹

Within the kidney, prostaglandins, primarily prostaglandin E₂ and prostaglandin I₂, are synthesized in discrete regions along the course of the nephron. Their effects are localized to the immediate areas of origin.² Stimulation of intrarenal prostaglandin production causes dilatation of the renal vasculature, reduces salt and water reabsorption, and increases renin release. During a normal state of volemia, production of these prostaglandins is minimal, and they have little part to play in minute to minute regulation of renal function. However, in clinical situations with decreased effective blood volume, their role may become critical. Such situations include congestive heart failure, cirrhosis, nephrotic syndrome, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?